Clinical trials
Optic Neuritis trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 3 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 3 |
| Accure Therapeutics | 1 |
| Biogen | 1 |
| Daval International Limited | 1 |
| EMD Serono | 1 |
| Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul | 1 |
| King's College London | 1 |
| MedDay Pharmaceuticals SA | 1 |
| University College, London | 1 |
| University of Cambridge | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Optic Neuritis | 13 |
| Multiple Sclerosis | 6 |
| Demyelinating Diseases | 5 |
| Neuromyelitis Optica | 4 |
| Myelitis, Transverse | 3 |
| Recurrence | 3 |
| Multiple Sclerosis, Chronic Progressive | 2 |
| Neuritis | 2 |
| Genetic Risk Score | 1 |
| Multiple Sclerosis, Relapsing-Remitting | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.